nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—UGT2B7—urinary bladder cancer	0.751	1	CbGaD
Oxazepam—UGT2B7—Epirubicin—urinary bladder cancer	0.0399	0.612	CbGbCtD
Oxazepam—CYP3A4—Thiotepa—urinary bladder cancer	0.0118	0.181	CbGbCtD
Oxazepam—CYP3A5—Etoposide—urinary bladder cancer	0.00818	0.126	CbGbCtD
Oxazepam—CYP3A4—Etoposide—urinary bladder cancer	0.00319	0.0489	CbGbCtD
Oxazepam—UGT2B15—prostate gland—urinary bladder cancer	0.00239	0.106	CbGeAlD
Oxazepam—CYP3A4—Doxorubicin—urinary bladder cancer	0.00218	0.0334	CbGbCtD
Oxazepam—Slurred speech—Fluorouracil—urinary bladder cancer	0.00185	0.0305	CcSEcCtD
Oxazepam—Slurred speech—Cisplatin—urinary bladder cancer	0.00175	0.0289	CcSEcCtD
Oxazepam—Midazolam—CYP4B1—urinary bladder cancer	0.00166	0.426	CrCbGaD
Oxazepam—UGT2B15—urethra—urinary bladder cancer	0.0016	0.0711	CbGeAlD
Oxazepam—UGT2B7—prostate gland—urinary bladder cancer	0.00146	0.0649	CbGeAlD
Oxazepam—UGT2B15—female reproductive system—urinary bladder cancer	0.00131	0.058	CbGeAlD
Oxazepam—Memory impairment—Thiotepa—urinary bladder cancer	0.00127	0.021	CcSEcCtD
Oxazepam—UGT1A9—renal system—urinary bladder cancer	0.00124	0.0549	CbGeAlD
Oxazepam—GABRP—prostate gland—urinary bladder cancer	0.0012	0.0534	CbGeAlD
Oxazepam—Drowsiness—Mitomycin—urinary bladder cancer	0.00111	0.0184	CcSEcCtD
Oxazepam—CYP3A4—urine—urinary bladder cancer	0.00111	0.0493	CbGeAlD
Oxazepam—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00104	0.266	CrCbGaD
Oxazepam—Clonazepam—NAT2—urinary bladder cancer	0.00103	0.264	CrCbGaD
Oxazepam—UGT2B7—renal system—urinary bladder cancer	0.000996	0.0442	CbGeAlD
Oxazepam—GABRE—prostate gland—urinary bladder cancer	0.000918	0.0408	CbGeAlD
Oxazepam—Dysarthria—Fluorouracil—urinary bladder cancer	0.000874	0.0144	CcSEcCtD
Oxazepam—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000841	0.0139	CcSEcCtD
Oxazepam—Dysarthria—Cisplatin—urinary bladder cancer	0.000828	0.0137	CcSEcCtD
Oxazepam—Vision blurred—Mitomycin—urinary bladder cancer	0.000819	0.0135	CcSEcCtD
Oxazepam—Abdominal pain—Valrubicin—urinary bladder cancer	0.000813	0.0134	CcSEcCtD
Oxazepam—Body temperature increased—Valrubicin—urinary bladder cancer	0.000813	0.0134	CcSEcCtD
Oxazepam—GABRP—urethra—urinary bladder cancer	0.000805	0.0357	CbGeAlD
Oxazepam—UGT2B7—female reproductive system—urinary bladder cancer	0.000798	0.0354	CbGeAlD
Oxazepam—Syncope—Mitomycin—urinary bladder cancer	0.000779	0.0129	CcSEcCtD
Oxazepam—GABRB3—prostate gland—urinary bladder cancer	0.000778	0.0345	CbGeAlD
Oxazepam—Leukopenia—Mitomycin—urinary bladder cancer	0.000778	0.0128	CcSEcCtD
Oxazepam—GABRE—seminal vesicle—urinary bladder cancer	0.000776	0.0345	CbGeAlD
Oxazepam—Loss of consciousness—Mitomycin—urinary bladder cancer	0.000763	0.0126	CcSEcCtD
Oxazepam—Body temperature increased—Carboplatin—urinary bladder cancer	0.000753	0.0124	CcSEcCtD
Oxazepam—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00071	0.0117	CcSEcCtD
Oxazepam—Oedema—Mitomycin—urinary bladder cancer	0.000709	0.0117	CcSEcCtD
Oxazepam—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.000698	0.0115	CcSEcCtD
Oxazepam—Shock—Mitomycin—urinary bladder cancer	0.000697	0.0115	CcSEcCtD
Oxazepam—Ataxia—Thiotepa—urinary bladder cancer	0.000682	0.0113	CcSEcCtD
Oxazepam—Dizziness—Valrubicin—urinary bladder cancer	0.00068	0.0112	CcSEcCtD
Oxazepam—Disorientation—Fluorouracil—urinary bladder cancer	0.000671	0.0111	CcSEcCtD
Oxazepam—GABRB1—vagina—urinary bladder cancer	0.000663	0.0294	CbGeAlD
Oxazepam—GABRP—female reproductive system—urinary bladder cancer	0.000656	0.0291	CbGeAlD
Oxazepam—Rash—Valrubicin—urinary bladder cancer	0.000649	0.0107	CcSEcCtD
Oxazepam—Dermatitis—Valrubicin—urinary bladder cancer	0.000648	0.0107	CcSEcCtD
Oxazepam—Headache—Valrubicin—urinary bladder cancer	0.000645	0.0106	CcSEcCtD
Oxazepam—Amnesia—Fluorouracil—urinary bladder cancer	0.000639	0.0105	CcSEcCtD
Oxazepam—Somnolence—Mitomycin—urinary bladder cancer	0.00063	0.0104	CcSEcCtD
Oxazepam—GABRE—urethra—urinary bladder cancer	0.000615	0.0273	CbGeAlD
Oxazepam—Lethargy—Fluorouracil—urinary bladder cancer	0.000612	0.0101	CcSEcCtD
Oxazepam—Nausea—Valrubicin—urinary bladder cancer	0.000611	0.0101	CcSEcCtD
Oxazepam—Amnesia—Cisplatin—urinary bladder cancer	0.000605	0.00999	CcSEcCtD
Oxazepam—GABRP—vagina—urinary bladder cancer	0.000594	0.0264	CbGeAlD
Oxazepam—Stupor—Methotrexate—urinary bladder cancer	0.000576	0.00951	CcSEcCtD
Oxazepam—Ataxia—Fluorouracil—urinary bladder cancer	0.000564	0.00931	CcSEcCtD
Oxazepam—Body temperature increased—Mitomycin—urinary bladder cancer	0.00056	0.00925	CcSEcCtD
Oxazepam—GABRR2—lymph node—urinary bladder cancer	0.000549	0.0244	CbGeAlD
Oxazepam—Jaundice—Thiotepa—urinary bladder cancer	0.000545	0.009	CcSEcCtD
Oxazepam—CYP3A5—prostate gland—urinary bladder cancer	0.000531	0.0236	CbGeAlD
Oxazepam—Agranulocytosis—Thiotepa—urinary bladder cancer	0.000522	0.00861	CcSEcCtD
Oxazepam—GABRE—female reproductive system—urinary bladder cancer	0.000501	0.0222	CbGeAlD
Oxazepam—Hallucination—Thiotepa—urinary bladder cancer	0.000499	0.00824	CcSEcCtD
Oxazepam—Blood disorder—Epirubicin—urinary bladder cancer	0.000482	0.00795	CcSEcCtD
Oxazepam—Dizziness—Mitomycin—urinary bladder cancer	0.000469	0.00774	CcSEcCtD
Oxazepam—GABRA2—vagina—urinary bladder cancer	0.000457	0.0203	CbGeAlD
Oxazepam—Dysarthria—Methotrexate—urinary bladder cancer	0.000455	0.0075	CcSEcCtD
Oxazepam—GABRE—vagina—urinary bladder cancer	0.000453	0.0201	CbGeAlD
Oxazepam—Rash—Mitomycin—urinary bladder cancer	0.000447	0.00738	CcSEcCtD
Oxazepam—Dermatitis—Mitomycin—urinary bladder cancer	0.000447	0.00737	CcSEcCtD
Oxazepam—Blood disorder—Doxorubicin—urinary bladder cancer	0.000446	0.00736	CcSEcCtD
Oxazepam—Headache—Mitomycin—urinary bladder cancer	0.000444	0.00733	CcSEcCtD
Oxazepam—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000439	0.00724	CcSEcCtD
Oxazepam—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000431	0.00712	CcSEcCtD
Oxazepam—Dysarthria—Epirubicin—urinary bladder cancer	0.000425	0.00702	CcSEcCtD
Oxazepam—GABRB3—female reproductive system—urinary bladder cancer	0.000425	0.0189	CbGeAlD
Oxazepam—Nausea—Mitomycin—urinary bladder cancer	0.000421	0.00695	CcSEcCtD
Oxazepam—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.000415	0.00685	CcSEcCtD
Oxazepam—Vision blurred—Thiotepa—urinary bladder cancer	0.000412	0.0068	CcSEcCtD
Oxazepam—Agitation—Thiotepa—urinary bladder cancer	0.000401	0.00663	CcSEcCtD
Oxazepam—Dysarthria—Doxorubicin—urinary bladder cancer	0.000394	0.0065	CcSEcCtD
Oxazepam—Jaundice—Etoposide—urinary bladder cancer	0.000391	0.00646	CcSEcCtD
Oxazepam—Leukopenia—Thiotepa—urinary bladder cancer	0.000391	0.00646	CcSEcCtD
Oxazepam—Agranulocytosis—Etoposide—urinary bladder cancer	0.000375	0.00619	CcSEcCtD
Oxazepam—CYP3A5—renal system—urinary bladder cancer	0.000362	0.0161	CbGeAlD
Oxazepam—Vision blurred—Fluorouracil—urinary bladder cancer	0.00034	0.00562	CcSEcCtD
Oxazepam—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.000334	0.00552	CcSEcCtD
Oxazepam—Leukopenia—Gemcitabine—urinary bladder cancer	0.000329	0.00543	CcSEcCtD
Oxazepam—Leukopenia—Fluorouracil—urinary bladder cancer	0.000323	0.00534	CcSEcCtD
Oxazepam—Vision blurred—Cisplatin—urinary bladder cancer	0.000323	0.00533	CcSEcCtD
Oxazepam—Tremor—Cisplatin—urinary bladder cancer	0.000321	0.0053	CcSEcCtD
Oxazepam—Paraesthesia—Thiotepa—urinary bladder cancer	0.00032	0.00528	CcSEcCtD
Oxazepam—Lethargy—Methotrexate—urinary bladder cancer	0.000318	0.00526	CcSEcCtD
Oxazepam—Somnolence—Thiotepa—urinary bladder cancer	0.000317	0.00523	CcSEcCtD
Oxazepam—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000309	0.0051	CcSEcCtD
Oxazepam—Leukopenia—Cisplatin—urinary bladder cancer	0.000307	0.00506	CcSEcCtD
Oxazepam—Oedema—Gemcitabine—urinary bladder cancer	0.0003	0.00495	CcSEcCtD
Oxazepam—Lethargy—Epirubicin—urinary bladder cancer	0.000298	0.00492	CcSEcCtD
Oxazepam—GABRA2—lymph node—urinary bladder cancer	0.000296	0.0131	CbGeAlD
Oxazepam—Oedema—Fluorouracil—urinary bladder cancer	0.000295	0.00487	CcSEcCtD
Oxazepam—Ataxia—Methotrexate—urinary bladder cancer	0.000293	0.00484	CcSEcCtD
Oxazepam—GABRE—lymph node—urinary bladder cancer	0.000293	0.013	CbGeAlD
Oxazepam—Diplopia—Epirubicin—urinary bladder cancer	0.000292	0.00482	CcSEcCtD
Oxazepam—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000292	0.00481	CcSEcCtD
Oxazepam—Vertigo—Etoposide—urinary bladder cancer	0.000282	0.00465	CcSEcCtD
Oxazepam—Abdominal pain—Thiotepa—urinary bladder cancer	0.000282	0.00465	CcSEcCtD
Oxazepam—Body temperature increased—Thiotepa—urinary bladder cancer	0.000282	0.00465	CcSEcCtD
Oxazepam—Leukopenia—Etoposide—urinary bladder cancer	0.000281	0.00464	CcSEcCtD
Oxazepam—Hypotension—Gemcitabine—urinary bladder cancer	0.00028	0.00463	CcSEcCtD
Oxazepam—Oedema—Cisplatin—urinary bladder cancer	0.00028	0.00461	CcSEcCtD
Oxazepam—Loss of consciousness—Etoposide—urinary bladder cancer	0.000276	0.00455	CcSEcCtD
Oxazepam—Lethargy—Doxorubicin—urinary bladder cancer	0.000276	0.00455	CcSEcCtD
Oxazepam—Hypotension—Fluorouracil—urinary bladder cancer	0.000276	0.00455	CcSEcCtD
Oxazepam—Ataxia—Epirubicin—urinary bladder cancer	0.000275	0.00453	CcSEcCtD
Oxazepam—CYP3A4—renal system—urinary bladder cancer	0.000271	0.0121	CbGeAlD
Oxazepam—Diplopia—Doxorubicin—urinary bladder cancer	0.00027	0.00446	CcSEcCtD
Oxazepam—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000269	0.00445	CcSEcCtD
Oxazepam—Somnolence—Gemcitabine—urinary bladder cancer	0.000267	0.0044	CcSEcCtD
Oxazepam—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000265	0.00437	CcSEcCtD
Oxazepam—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000263	0.00434	CcSEcCtD
Oxazepam—Somnolence—Fluorouracil—urinary bladder cancer	0.000262	0.00433	CcSEcCtD
Oxazepam—CYP3A5—vagina—urinary bladder cancer	0.000262	0.0116	CbGeAlD
Oxazepam—Hypotension—Cisplatin—urinary bladder cancer	0.000261	0.00431	CcSEcCtD
Oxazepam—Ataxia—Doxorubicin—urinary bladder cancer	0.000254	0.0042	CcSEcCtD
Oxazepam—Paraesthesia—Cisplatin—urinary bladder cancer	0.000251	0.00414	CcSEcCtD
Oxazepam—Drowsiness—Methotrexate—urinary bladder cancer	0.000241	0.00397	CcSEcCtD
Oxazepam—Hypotension—Etoposide—urinary bladder cancer	0.000239	0.00395	CcSEcCtD
Oxazepam—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000237	0.00391	CcSEcCtD
Oxazepam—Dizziness—Thiotepa—urinary bladder cancer	0.000236	0.00389	CcSEcCtD
Oxazepam—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000233	0.00385	CcSEcCtD
Oxazepam—Paraesthesia—Etoposide—urinary bladder cancer	0.00023	0.0038	CcSEcCtD
Oxazepam—Somnolence—Etoposide—urinary bladder cancer	0.000228	0.00376	CcSEcCtD
Oxazepam—Drowsiness—Epirubicin—urinary bladder cancer	0.000225	0.00372	CcSEcCtD
Oxazepam—Rash—Thiotepa—urinary bladder cancer	0.000225	0.00371	CcSEcCtD
Oxazepam—Dermatitis—Thiotepa—urinary bladder cancer	0.000225	0.00371	CcSEcCtD
Oxazepam—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000224	0.00371	CcSEcCtD
Oxazepam—Headache—Thiotepa—urinary bladder cancer	0.000223	0.00369	CcSEcCtD
Oxazepam—Body temperature increased—Cisplatin—urinary bladder cancer	0.000221	0.00365	CcSEcCtD
Oxazepam—Jaundice—Epirubicin—urinary bladder cancer	0.000219	0.00362	CcSEcCtD
Oxazepam—CYP3A4—female reproductive system—urinary bladder cancer	0.000217	0.00965	CbGeAlD
Oxazepam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000217	0.00359	CcSEcCtD
Oxazepam—Nausea—Thiotepa—urinary bladder cancer	0.000212	0.0035	CcSEcCtD
Oxazepam—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00021	0.00347	CcSEcCtD
Oxazepam—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000209	0.00346	CcSEcCtD
Oxazepam—Drowsiness—Doxorubicin—urinary bladder cancer	0.000208	0.00344	CcSEcCtD
Oxazepam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000206	0.0034	CcSEcCtD
Oxazepam—Jaundice—Doxorubicin—urinary bladder cancer	0.000203	0.00335	CcSEcCtD
Oxazepam—Abdominal pain—Etoposide—urinary bladder cancer	0.000202	0.00334	CcSEcCtD
Oxazepam—Body temperature increased—Etoposide—urinary bladder cancer	0.000202	0.00334	CcSEcCtD
Oxazepam—Dizziness—Fluorouracil—urinary bladder cancer	0.000195	0.00322	CcSEcCtD
Oxazepam—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000194	0.00321	CcSEcCtD
Oxazepam—Rash—Gemcitabine—urinary bladder cancer	0.000189	0.00312	CcSEcCtD
Oxazepam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000189	0.00312	CcSEcCtD
Oxazepam—Hypersensitivity—Etoposide—urinary bladder cancer	0.000189	0.00311	CcSEcCtD
Oxazepam—Headache—Gemcitabine—urinary bladder cancer	0.000188	0.0031	CcSEcCtD
Oxazepam—Rash—Fluorouracil—urinary bladder cancer	0.000186	0.00307	CcSEcCtD
Oxazepam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000186	0.00307	CcSEcCtD
Oxazepam—Headache—Fluorouracil—urinary bladder cancer	0.000185	0.00305	CcSEcCtD
Oxazepam—Nausea—Gemcitabine—urinary bladder cancer	0.000178	0.00294	CcSEcCtD
Oxazepam—Vision blurred—Methotrexate—urinary bladder cancer	0.000177	0.00292	CcSEcCtD
Oxazepam—Rash—Cisplatin—urinary bladder cancer	0.000176	0.00291	CcSEcCtD
Oxazepam—Dermatitis—Cisplatin—urinary bladder cancer	0.000176	0.00291	CcSEcCtD
Oxazepam—Nausea—Fluorouracil—urinary bladder cancer	0.000175	0.00289	CcSEcCtD
Oxazepam—Flurbiprofen—PTGS2—urinary bladder cancer	0.000171	0.0439	CrCbGaD
Oxazepam—Dizziness—Etoposide—urinary bladder cancer	0.000169	0.0028	CcSEcCtD
Oxazepam—Vertigo—Methotrexate—urinary bladder cancer	0.000169	0.00279	CcSEcCtD
Oxazepam—Leukopenia—Methotrexate—urinary bladder cancer	0.000168	0.00278	CcSEcCtD
Oxazepam—Nausea—Cisplatin—urinary bladder cancer	0.000166	0.00274	CcSEcCtD
Oxazepam—Vision blurred—Epirubicin—urinary bladder cancer	0.000166	0.00274	CcSEcCtD
Oxazepam—Agitation—Epirubicin—urinary bladder cancer	0.000162	0.00267	CcSEcCtD
Oxazepam—Rash—Etoposide—urinary bladder cancer	0.000161	0.00267	CcSEcCtD
Oxazepam—Dermatitis—Etoposide—urinary bladder cancer	0.000161	0.00266	CcSEcCtD
Oxazepam—Headache—Etoposide—urinary bladder cancer	0.00016	0.00265	CcSEcCtD
Oxazepam—Vertigo—Epirubicin—urinary bladder cancer	0.000158	0.00261	CcSEcCtD
Oxazepam—Syncope—Epirubicin—urinary bladder cancer	0.000158	0.0026	CcSEcCtD
Oxazepam—Leukopenia—Epirubicin—urinary bladder cancer	0.000157	0.0026	CcSEcCtD
Oxazepam—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000155	0.00255	CcSEcCtD
Oxazepam—Vision blurred—Doxorubicin—urinary bladder cancer	0.000153	0.00253	CcSEcCtD
Oxazepam—Nausea—Etoposide—urinary bladder cancer	0.000152	0.00251	CcSEcCtD
Oxazepam—Agitation—Doxorubicin—urinary bladder cancer	0.00015	0.00247	CcSEcCtD
Oxazepam—Vertigo—Doxorubicin—urinary bladder cancer	0.000146	0.00241	CcSEcCtD
Oxazepam—Syncope—Doxorubicin—urinary bladder cancer	0.000146	0.00241	CcSEcCtD
Oxazepam—Leukopenia—Doxorubicin—urinary bladder cancer	0.000146	0.0024	CcSEcCtD
Oxazepam—Oedema—Epirubicin—urinary bladder cancer	0.000144	0.00237	CcSEcCtD
Oxazepam—Hypotension—Methotrexate—urinary bladder cancer	0.000143	0.00237	CcSEcCtD
Oxazepam—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000143	0.00236	CcSEcCtD
Oxazepam—Shock—Epirubicin—urinary bladder cancer	0.000141	0.00233	CcSEcCtD
Oxazepam—Paraesthesia—Methotrexate—urinary bladder cancer	0.000138	0.00227	CcSEcCtD
Oxazepam—Somnolence—Methotrexate—urinary bladder cancer	0.000136	0.00225	CcSEcCtD
Oxazepam—Hypotension—Epirubicin—urinary bladder cancer	0.000134	0.00221	CcSEcCtD
Oxazepam—Oedema—Doxorubicin—urinary bladder cancer	0.000133	0.00219	CcSEcCtD
Oxazepam—Shock—Doxorubicin—urinary bladder cancer	0.000131	0.00216	CcSEcCtD
Oxazepam—Paraesthesia—Epirubicin—urinary bladder cancer	0.000129	0.00213	CcSEcCtD
Oxazepam—Somnolence—Epirubicin—urinary bladder cancer	0.000128	0.00211	CcSEcCtD
Oxazepam—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000125	0.00207	CcSEcCtD
Oxazepam—Hypotension—Doxorubicin—urinary bladder cancer	0.000124	0.00205	CcSEcCtD
Oxazepam—Abdominal pain—Methotrexate—urinary bladder cancer	0.000121	0.002	CcSEcCtD
Oxazepam—Body temperature increased—Methotrexate—urinary bladder cancer	0.000121	0.002	CcSEcCtD
Oxazepam—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000119	0.00197	CcSEcCtD
Oxazepam—Somnolence—Doxorubicin—urinary bladder cancer	0.000118	0.00195	CcSEcCtD
Oxazepam—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000117	0.00194	CcSEcCtD
Oxazepam—Body temperature increased—Epirubicin—urinary bladder cancer	0.000113	0.00187	CcSEcCtD
Oxazepam—Abdominal pain—Epirubicin—urinary bladder cancer	0.000113	0.00187	CcSEcCtD
Oxazepam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000113	0.00187	CcSEcCtD
Oxazepam—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000109	0.00179	CcSEcCtD
Oxazepam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000106	0.00175	CcSEcCtD
Oxazepam—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000105	0.00173	CcSEcCtD
Oxazepam—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000105	0.00173	CcSEcCtD
Oxazepam—Dizziness—Methotrexate—urinary bladder cancer	0.000101	0.00167	CcSEcCtD
Oxazepam—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.79e-05	0.00162	CcSEcCtD
Oxazepam—Rash—Methotrexate—urinary bladder cancer	9.67e-05	0.0016	CcSEcCtD
Oxazepam—Dermatitis—Methotrexate—urinary bladder cancer	9.66e-05	0.0016	CcSEcCtD
Oxazepam—Headache—Methotrexate—urinary bladder cancer	9.61e-05	0.00159	CcSEcCtD
Oxazepam—Dizziness—Epirubicin—urinary bladder cancer	9.49e-05	0.00157	CcSEcCtD
Oxazepam—Nausea—Methotrexate—urinary bladder cancer	9.11e-05	0.0015	CcSEcCtD
Oxazepam—Rash—Epirubicin—urinary bladder cancer	9.05e-05	0.00149	CcSEcCtD
Oxazepam—Dermatitis—Epirubicin—urinary bladder cancer	9.04e-05	0.00149	CcSEcCtD
Oxazepam—Headache—Epirubicin—urinary bladder cancer	8.99e-05	0.00148	CcSEcCtD
Oxazepam—Dizziness—Doxorubicin—urinary bladder cancer	8.78e-05	0.00145	CcSEcCtD
Oxazepam—Nausea—Epirubicin—urinary bladder cancer	8.53e-05	0.00141	CcSEcCtD
Oxazepam—Rash—Doxorubicin—urinary bladder cancer	8.37e-05	0.00138	CcSEcCtD
Oxazepam—Dermatitis—Doxorubicin—urinary bladder cancer	8.37e-05	0.00138	CcSEcCtD
Oxazepam—Headache—Doxorubicin—urinary bladder cancer	8.32e-05	0.00137	CcSEcCtD
Oxazepam—Nausea—Doxorubicin—urinary bladder cancer	7.89e-05	0.0013	CcSEcCtD
Oxazepam—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.27e-05	0.000542	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.2e-05	0.000535	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—EP300—urinary bladder cancer	5.19e-05	0.000534	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTZ1—urinary bladder cancer	5.16e-05	0.000531	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	5.14e-05	0.000529	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	5.12e-05	0.000527	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	5.08e-05	0.000523	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.07e-05	0.000521	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.05e-05	0.00052	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP4B1—urinary bladder cancer	4.96e-05	0.00051	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTO2—urinary bladder cancer	4.89e-05	0.000503	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NAT1—urinary bladder cancer	4.89e-05	0.000503	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.84e-05	0.000497	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.84e-05	0.000497	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—RRM2—urinary bladder cancer	4.83e-05	0.000497	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.81e-05	0.000495	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.76e-05	0.000489	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	4.71e-05	0.000484	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SLC19A1—urinary bladder cancer	4.68e-05	0.000482	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NQO1—urinary bladder cancer	4.67e-05	0.00048	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.64e-05	0.000477	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.62e-05	0.000475	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PRSS3—urinary bladder cancer	4.57e-05	0.000469	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.54e-05	0.000467	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ENO2—urinary bladder cancer	4.48e-05	0.00046	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—HPGDS—urinary bladder cancer	4.48e-05	0.00046	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—UGT2B7—urinary bladder cancer	4.48e-05	0.00046	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.46e-05	0.000459	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.43e-05	0.000456	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	4.43e-05	0.000456	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	4.37e-05	0.000449	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.35e-05	0.000448	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	4.34e-05	0.000446	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTT1—urinary bladder cancer	4.34e-05	0.000446	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	4.34e-05	0.000446	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	4.19e-05	0.000431	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	4.12e-05	0.000423	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NAT1—urinary bladder cancer	4.12e-05	0.000423	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP4B1—urinary bladder cancer	4.03e-05	0.000414	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.98e-05	0.000409	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.92e-05	0.000403	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTP1—urinary bladder cancer	3.89e-05	0.0004	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.81e-05	0.000392	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SLC19A1—urinary bladder cancer	3.81e-05	0.000391	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.81e-05	0.000391	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	3.77e-05	0.000387	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.71e-05	0.000382	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PRSS3—urinary bladder cancer	3.71e-05	0.000381	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.67e-05	0.000377	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TYMP—urinary bladder cancer	3.65e-05	0.000375	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.64e-05	0.000374	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.64e-05	0.000374	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—TYMS—urinary bladder cancer	3.62e-05	0.000372	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NQO1—urinary bladder cancer	3.61e-05	0.000371	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	3.59e-05	0.000369	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NCOR1—urinary bladder cancer	3.58e-05	0.000368	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTM1—urinary bladder cancer	3.58e-05	0.000368	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	3.54e-05	0.000364	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	3.5e-05	0.00036	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	3.44e-05	0.000353	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GPX1—urinary bladder cancer	3.43e-05	0.000352	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	3.39e-05	0.000349	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.37e-05	0.000346	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ERCC2—urinary bladder cancer	3.36e-05	0.000346	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.35e-05	0.000345	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NAT2—urinary bladder cancer	3.3e-05	0.000339	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.26e-05	0.000335	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.21e-05	0.00033	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.21e-05	0.00033	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	3.2e-05	0.000329	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.2e-05	0.000329	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—MTHFR—urinary bladder cancer	3.16e-05	0.000325	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.14e-05	0.000323	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	3.14e-05	0.000323	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.12e-05	0.000321	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	3.12e-05	0.000321	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	3.07e-05	0.000315	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	3.05e-05	0.000314	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTP1—urinary bladder cancer	3.01e-05	0.000309	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.99e-05	0.000308	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NAT1—urinary bladder cancer	2.98e-05	0.000306	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	2.98e-05	0.000306	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.97e-05	0.000306	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TYMP—urinary bladder cancer	2.97e-05	0.000305	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.95e-05	0.000303	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—HRAS—urinary bladder cancer	2.92e-05	0.0003	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	2.92e-05	0.0003	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—RRM2—urinary bladder cancer	2.85e-05	0.000293	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.85e-05	0.000293	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TYMS—urinary bladder cancer	2.8e-05	0.000288	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.79e-05	0.000287	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—HRAS—urinary bladder cancer	2.79e-05	0.000286	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—HRAS—urinary bladder cancer	2.79e-05	0.000286	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NCOR1—urinary bladder cancer	2.77e-05	0.000284	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTM1—urinary bladder cancer	2.77e-05	0.000284	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.76e-05	0.000283	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	2.72e-05	0.00028	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NAT2—urinary bladder cancer	2.68e-05	0.000276	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	2.68e-05	0.000276	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GPX1—urinary bladder cancer	2.65e-05	0.000272	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.65e-05	0.000272	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—HPGDS—urinary bladder cancer	2.64e-05	0.000271	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ENO2—urinary bladder cancer	2.64e-05	0.000271	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.61e-05	0.000268	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ERCC2—urinary bladder cancer	2.6e-05	0.000267	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PPARG—urinary bladder cancer	2.56e-05	0.000264	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTT1—urinary bladder cancer	2.56e-05	0.000263	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.52e-05	0.000259	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TYMP—urinary bladder cancer	2.49e-05	0.000256	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.47e-05	0.000254	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CREBBP—urinary bladder cancer	2.46e-05	0.000253	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	2.45e-05	0.000252	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.45e-05	0.000252	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MTHFR—urinary bladder cancer	2.44e-05	0.000251	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.44e-05	0.00025	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.4e-05	0.000247	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.38e-05	0.000245	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.36e-05	0.000243	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.35e-05	0.000242	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.35e-05	0.000241	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—RRM2—urinary bladder cancer	2.32e-05	0.000238	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	2.31e-05	0.000238	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.31e-05	0.000237	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—HRAS—urinary bladder cancer	2.29e-05	0.000236	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—HRAS—urinary bladder cancer	2.26e-05	0.000232	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NAT2—urinary bladder cancer	2.26e-05	0.000232	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	2.26e-05	0.000232	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.23e-05	0.000229	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.19e-05	0.000225	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.16e-05	0.000222	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.16e-05	0.000222	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	2.14e-05	0.00022	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ENO2—urinary bladder cancer	2.14e-05	0.00022	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—HRAS—urinary bladder cancer	2.14e-05	0.00022	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.13e-05	0.000219	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NQO1—urinary bladder cancer	2.13e-05	0.000219	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.12e-05	0.000218	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—HRAS—urinary bladder cancer	2.11e-05	0.000217	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.09e-05	0.000215	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	2.08e-05	0.000214	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.07e-05	0.000213	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.05e-05	0.000211	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.04e-05	0.000209	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTGS2—urinary bladder cancer	2.02e-05	0.000207	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.01e-05	0.000207	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PPARG—urinary bladder cancer	1.98e-05	0.000204	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—RRM2—urinary bladder cancer	1.95e-05	0.0002	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	1.93e-05	0.000199	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CREBBP—urinary bladder cancer	1.9e-05	0.000196	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—HRAS—urinary bladder cancer	1.88e-05	0.000193	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—HRAS—urinary bladder cancer	1.84e-05	0.000189	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—HRAS—urinary bladder cancer	1.81e-05	0.000186	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	1.8e-05	0.000185	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ENO2—urinary bladder cancer	1.8e-05	0.000185	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TYMP—urinary bladder cancer	1.8e-05	0.000185	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—HRAS—urinary bladder cancer	1.8e-05	0.000185	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.78e-05	0.000183	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.77e-05	0.000182	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	1.77e-05	0.000182	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTEN—urinary bladder cancer	1.76e-05	0.000181	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.00018	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NQO1—urinary bladder cancer	1.73e-05	0.000178	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—EP300—urinary bladder cancer	1.68e-05	0.000173	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.68e-05	0.000172	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.65e-05	0.00017	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.63e-05	0.000168	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.63e-05	0.000168	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.63e-05	0.000168	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.56e-05	0.00016	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTGS2—urinary bladder cancer	1.56e-05	0.00016	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	1.54e-05	0.000159	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.53e-05	0.000158	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.46e-05	0.00015	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.46e-05	0.00015	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NQO1—urinary bladder cancer	1.45e-05	0.000149	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	1.44e-05	0.000148	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.44e-05	0.000148	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000145	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.39e-05	0.000143	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.38e-05	0.000142	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.38e-05	0.000142	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTEN—urinary bladder cancer	1.36e-05	0.00014	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TYMS—urinary bladder cancer	1.34e-05	0.000138	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	1.32e-05	0.000136	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	1.32e-05	0.000136	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.3e-05	0.000134	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	0.000134	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—EP300—urinary bladder cancer	1.3e-05	0.000133	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GPX1—urinary bladder cancer	1.27e-05	0.00013	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.27e-05	0.00013	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	0.00013	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000128	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	0.000125	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	0.00012	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PPARG—urinary bladder cancer	1.17e-05	0.00012	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.14e-05	0.000117	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.13e-05	0.000116	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	1.12e-05	0.000115	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	0.000115	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	0.000115	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.08e-05	0.000111	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.07e-05	0.00011	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.05e-05	0.000108	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.05e-05	0.000108	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	0.000108	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	9.85e-06	0.000101	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PPARG—urinary bladder cancer	9.49e-06	9.76e-05	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	9.19e-06	9.45e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	9.12e-06	9.38e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	8.76e-06	9.01e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	8.38e-06	8.62e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TYMS—urinary bladder cancer	8.15e-06	8.38e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	8.05e-06	8.28e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	8.05e-06	8.28e-05	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTEN—urinary bladder cancer	8.01e-06	8.24e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PPARG—urinary bladder cancer	7.98e-06	8.21e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GPX1—urinary bladder cancer	7.71e-06	7.93e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	7.67e-06	7.88e-05	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—EP300—urinary bladder cancer	7.64e-06	7.86e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	7.58e-06	7.79e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	7.57e-06	7.78e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	7.47e-06	7.68e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	7.12e-06	7.32e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	6.54e-06	6.73e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTEN—urinary bladder cancer	6.51e-06	6.7e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	6.28e-06	6.46e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—EP300—urinary bladder cancer	6.21e-06	6.39e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.06e-06	6.23e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.06e-06	6.23e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.88e-06	6.04e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PPARG—urinary bladder cancer	5.77e-06	5.93e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	5.54e-06	5.7e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTEN—urinary bladder cancer	5.48e-06	5.63e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—EP300—urinary bladder cancer	5.22e-06	5.37e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.88e-06	5.02e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	4.54e-06	4.67e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.07e-06	4.19e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.96e-06	4.07e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.79e-06	3.89e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.78e-06	3.88e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.74e-06	3.85e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.74e-06	3.85e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.59e-06	3.69e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.52e-06	3.62e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.31e-06	3.4e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.68e-06	2.76e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.58e-06	2.65e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.11e-06	2.17e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.84e-06	1.89e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.76e-06	1.8e-05	CbGpPWpGaD
